Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04388527 · ClinicalTrials.gov registry record · Phase 1
COVID-19 Convalescent Plasma for Mechanically Ventilated Population
A Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT04388527: Completed Phase 1 study, sponsored by University of Pennsylvania.
NCT04388527 is a Phase 1 study that has completed, run by University of Pennsylvania. The registered enrollment target is 32 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04388527, a Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to see if this plasma can be safely used in humans with COVID-19 and to see if it can improve patients' health when they are sick with COVID-19.
Primary Outcome
Cumulative incidence of participants with at least one serious adverse events (SAEs) at Study Day 29.
Interventions
- BIOLOGICAL COVID-19 Convalescent Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-04-30 |
| Est. Completion | 2021-01-30 |
| Phase | Phase 1 |
What the finished NCT04388527 record still lists
NCT04388527 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 1 intervention - of which COVID-19 Convalescent Plasma is the first listed.
NCT04388527 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04388527 about?
NCT04388527 is a clinical study titled "COVID-19 Convalescent Plasma for Mechanically Ventilated Population". The purpose of this study is to see if this plasma can be safely used in humans with COVID-19 and to see if it can improve patients' health when they are sick with COVID-19.
What is the current status of trial NCT04388527?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2020-04-30. Estimated completion is 2021-01-30.
What interventions are being tested in trial NCT04388527?
The interventions under investigation include: COVID-19 Convalescent Plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT04388527?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04388527's enrollment target sits among peer trials
32 1296th of 2000 higher than 679 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI